Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen
- 18 September 2014
- journal article
- case report
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 44 (6) , 528-532
- https://doi.org/10.1016/j.ijantimicag.2014.07.026
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Ribavirin and Interferon-α2b as Primary and Preventive Treatment for Middle East Respiratory Syndrome Coronavirus: A Preliminary Report of Two CasesAntiviral Therapy, 2015
- A case of imported Middle East Respiratory Syndrome coronavirus infection and public health response, Greece, April 2014Eurosurveillance, 2014
- What are our pharmacotherapeutic options for MERS-CoV?Expert Review of Clinical Pharmacology, 2014
- Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational studyInternational Journal of Infectious Diseases, 2014
- Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigationPublished by Elsevier ,2013
- Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaquesNature Medicine, 2013
- Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapyInternational Journal of Infectious Diseases, 2013
- Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological studyPublished by Elsevier ,2013
- Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infectionsEurosurveillance, 2012
- Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reactionEurosurveillance, 2012